Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2008 1
2009 1
2010 3
2011 4
2012 2
2013 1
2014 7
2015 4
2016 2
2017 1
2018 2
2019 2
2020 3
2021 2
2022 2
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
Mulleners WM, Kim BK, Láinez MJA, Lanteri-Minet M, Pozo-Rosich P, Wang S, Tockhorn-Heidenreich A, Aurora SK, Nichols RM, Yunes-Medina L, Detke HC. Mulleners WM, et al. Among authors: detke hc. Lancet Neurol. 2020 Oct;19(10):814-825. doi: 10.1016/S1474-4422(20)30279-9. Epub 2020 Sep 16. Lancet Neurol. 2020. PMID: 32949542 Clinical Trial.
Approvals and indications of CGRP antibodies.
Nichols R, Detke HC, Hundemer HP, Aurora SK. Nichols R, et al. Among authors: detke hc. Lancet Neurol. 2019 Aug;18(8):718. doi: 10.1016/S1474-4422(19)30229-7. Lancet Neurol. 2019. PMID: 31301747 No abstract available.
Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN).
Tobin JA, Joshi S, Ford JH, Nichols RM, Foster SA, Ruff D, Detke HC, Aurora SK. Tobin JA, et al. Among authors: detke hc. J Med Econ. 2022 Jan-Dec;25(1):1030-1038. doi: 10.1080/13696998.2022.2109335. J Med Econ. 2022. PMID: 35971655 Free article. Clinical Trial.
36 results